Modified-release hydrocortisone (Efmody®) in children with congenital adrenal hyperplasia: a retrospective registry study - Top-Institutions - MDSpire

Modified-release hydrocortisone (Efmody®) in children with congenital adrenal hyperplasia: a retrospective registry study

  • By

  • Erwin Lankes

  • Levin Wiebelt

  • Kathrin Bettina Helge

  • Dirk Schnabel

  • Peter Kühnen

  • Oliver Blankenstein

  • Uta Neumann

  • July 7, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    I-CAH registry
    I-CAH registry

    London, England

    Key Differentiators

    • Pediatrics

  • #2

    Robert-Koch-Institute (RKI)
    Robert-Koch-Institute (RKI)

    Berlin, Germany

    Key Differentiators

    • Pediatrics

  • #3

    REMAP-CAP consortium
    REMAP-CAP consortium

    N/A, N/A

    Key Differentiators

    • Pediatrics

Original Source(s)

Modified-release hydrocortisone (Efmody®) in children with congenital adrenal hyperplasia: a retrospective registry study

  • by Erwin Lankes, Levin Wiebelt, Kathrin Bettina Helge, Dirk Schnabel, Peter Kühnen, Oliver Blankenstein, Uta Neumann

  • July 7, 2026

Related Content

Comparative outcomes of transcranial craniotomy and endoscopic endonasal surgery for craniopharyngioma: a single-center retrospective cohort study

Incidental thyroid carcinoma in surgically treated multinodular goiter: a retrospective study

Hyperparathyroidism: current concepts in diagnosis and surgical treatment